Providence Thoracic Oncology Program emphasizes a multidisciplinary approach to cancer management. Our clinical trials program offers a broad array of innovative clinical research, including studies of new surgical techniques, radiation, chemotherapy, targeted therapy and immunotherapy agents, and tissue banking. Rachel E. Sanborn, M.D., specializes in thoracic oncology and clinical research, studying new agents or combinations in the treatment of lung cancer, mesothelioma and other thoracic tumors.
Patients can access the latest heart and vascular therapies, which are currently available only through clinical research studies.
Brendan D. Curti, M.D., focuses on developing immunotherapies to treat malignancies of the prostate, kidney and bladder.